litlas
Log inCreate account

Olli Kallioniemi

Active 1987–2025

190
Papers
49,478
Citations
117
h-index
186
i10-index

Citations

Citations per year for Olli Kallioniemi1986: 2 citations1987: 2 citations1988: 7 citations1989: 15 citations1990: 25 citations1991: 10 citations1992: 15 citations1993: 56 citations1994: 104 citations1995: 139 citations1996: 80 citations1997: 213 citations1998: 315 citations1999: 446 citations2000: 480 citations2001: 537 citations2002: 569 citations2003: 577 citations2004: 644 citations2005: 523 citations2006: 497 citations2007: 414 citations2008: 382 citations2009: 333 citations2010: 334 citations2011: 380 citations2012: 436 citations2013: 455 citations2014: 404 citations2015: 404 citations2016: 394 citations2017: 379 citations2018: 363 citations2019: 1,074 citations2020: 1,061 citations2021: 965 citations2022: 652 citations2023: 446 citations2024: 664 citations2025: 285 citations2026: 24 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,638 citing papers, 28.5% of this breakdownUnited Kingdom: 1,455 citing papers, 7.3% of this breakdownChina: 1,390 citing papers, 7% of this breakdownGermany: 1,124 citing papers, 5.7% of this breakdownFinland: 823 citing papers, 4.1% of this breakdownCanada: 765 citing papers, 3.9% of this breakdownFrance: 674 citing papers, 3.4% of this breakdownItaly: 650 citing papers, 3.3% of this breakdownSweden: 585 citing papers, 2.9% of this breakdownNetherlands: 567 citing papers, 2.9% of this breakdownAustralia: 503 citing papers, 2.5% of this breakdownJapan: 473 citing papers, 2.4% of this breakdown
0%28.5%Other 26.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology53%
  • Medicine36.3%
  • Computer Science3.1%
  • Immunology and Microbiology2.3%
  • Neuroscience2%
  • Engineering0.9%
  • Other2.4%

Topics

  • Cancer Genomics and Diagnostics3.4%
  • Prostate Cancer Treatment and Research3.2%
  • BRCA gene mutations in cancer2.5%
  • Genomic variations and chromosomal abnormalities2.3%
  • Gene expression and cancer classification2%
  • Estrogen and related hormone effects1.8%
  • Other84.8%

Coauthors

All papers

Open in search
  1. A community effort to assess and improve drug sensitivity prediction algorithms

    Authors: NCI DREAM Community, James C. Costello, Laura M. Heiser, Elisabeth Georgii, Mehmet Gönen, Michael P. Menden, Nicholas J. Wang, Mukesh Bansal, Muhammad Ammad-ud-din, Petteri Hintsanen, Suleiman A. Khan, John-Patrick Mpindi, Olli Kallioniemi, Antti Honkela, Tero Aittokallio, Krister Wennerberg, James J Collins, Dan Gallahan, Dinah S. Singer, Julio Sáez-Rodríguez, Samuel Kaski, Joe W. Gray, Gustavo Stolovitzky - Nature Biotechnology 2014 cited by 832

  2. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

    Authors: Antonis C. Antoniou, Paul D.P. Pharoah, Steven A. Narod, Harvey A. Risch, J.E. Eyfjörd, John L. Hopper, Niklas Loman, Håkan Olsson, Oskar T. Johannsson, Åke Borg, Barbara Pasini, Paolo Radice, Siranoush Manoukian, Diana Eccles, Nelson L.S. Tang, Edith Oláh, Hoda Anton‐Culver, Ellen Warner, Jan Lubiński, Jacek Gronwald, Bohdan Górski, Hrafn Tulinius, Steinunn Thorlacius, Hannaleena Eerola, Heli Nevanlinna, Kirsi Syrjäkoski, Olli Kallioniemi, Deborah J. Thompson, Chris Evans, Julian Peto, Fiona Lalloo, D. Gareth Evans, Douglas F. Easton - The American Journal of Human Genetics 2003 cited by 3,685

  3. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

    Authors: Disha Malani, Ashwini Kumar, Oscar Brück, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmäki, Olli Dufva, Matti Kankainen, Samuli Eldfors, Swapnil Potdar, Jani Saarela, Laura Turunen, Alun Parsons, Imre Västrik, Katja Kivinen, Janna Saarela, Riikka Räty, Minna Lehto, Maija Wolf, Bjørn Tore Gjertsen, Satu Mustjoki, Tero Aittokallio, Krister Wennerberg, Caroline A. Heckman, Olli Kallioniemi, Kimmo Porkka - Cancer Discovery 2021 cited by 198

  4. Break-Induced Replication Repair of Damaged Forks Induces Genomic Duplications in Human Cells

    Authors: Lorenzo Costantino, Sotirios K. Sotiriou, Juha Rantala, Simon Magin, Emil Mladenov, Thomas Helleday, James E. Haber, George Iliakis, Olli Kallioniemi, Thanos D. Halazonetis - Science 2013 cited by 448

  5. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

    Authors: Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Evgeny Kulesskiy, Mika Kontro, Riikka Karjalainen, Muntasir Mamun Majumder, Disha Malani, Astrid Murumägi, Jonathan C. Knowles, Kimmo Porkka, Caroline A. Heckman, Olli Kallioniemi, Krister Wennerberg, Tero Aittokallio - Scientific Reports 2014 cited by 369

  6. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer

    Authors: Biswajyoti Sahu, Marko Laakso, Kristian Ovaska, Tuomas Mirtti, Johan Lundin, Antti Rannikko, Anna Sankila, Juha-Pekka Turunen, Mikael Lundin, Juho Konsti, Tiina Vesterinen, Stig Nordling, Olli Kallioniemi, Sampsa Hautaniemi, Olli A. Jänne - The EMBO Journal 2011 cited by 399

  7. Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia

    Authors: Hanna Koskela, Samuli Eldfors, Pekka Ellonen, Arjan J. van Adrichem, Heikki Kuusanmäki, Emma Andersson, Sonja Lagström, Michael J. Clemente, Thomas L. Olson, Sari E. Jalkanen, Muntasir Mamun Majumder, Henrikki Almusa, Henrik Edgren, Maija Lepistö, Pirkko Mattila, Kathryn M Guinta, Pirjo Koistinen, Taru Kuittinen, Kati Penttinen, Alun Parsons, Jonathan C. Knowles, Janna Saarela, Krister Wennerberg, Olli Kallioniemi, Kimmo Porkka, Thomas P. Loughran, Caroline A. Heckman, Jaroslaw P. Maciejewski, Satu Mustjoki - New England Journal of Medicine 2012 cited by 766

  8. Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression

    Authors: Mika Hilvo, Carsten Denkert, Laura Lehtinen, Berit Müller, Scarlet Brockmöller, Tuulikki Seppänen‐Laakso, Jan Budczies, Elmar Bucher, Laxman Yetukuri, Sandra Castillo, Emilia Berg, Heli Nygrén, Marko Sysi‐Aho, Julian L. Griffin, Oliver Fiehn, Sibylle Loibl, Christiane Richter-Ehrenstein, Cornelia Radke, Tuulia Hyötyläinen, Olli Kallioniemi, Kristiina Iljin, Matej Orešič - Cancer Research 2011 cited by 535

  9. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data

    Authors: Daniel Nicorici, Mihaela Şatalan, Henrik Edgren, Sara Kangaspeska, Astrid Murumägi, Olli Kallioniemi, Sami Virtanen, Olavi Kilkku - 2014 cited by 403

  10. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features

    Authors: Teijo Pellinen, Lassi Paavolainen, Alfonso Martín-Bernabé, Renata Papatella Araujo, Carina Strell, Artur Mezheyeuski, Max Backman, Linnéa La Fleur, Oscar Brück, Jonas Sjölund, Erik Holmberg, Katja Välimäki, Hans Brunnström, Johan Botling, Pablo Moreno-Ruiz, Olli Kallioniemi, Patrick Micke, Arne Östman - JNCI Journal of the National Cancer Institute 2022 cited by 66

  11. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

    Authors: Maija Puhka, Maarit Takatalo, Maria-Elisa Nordberg, Sami Valkonen, Jatin Nandania, Maria Aatonen, Marjo Yliperttula, Saara Laitinen, Vidya Velagapudi, Tuomas Mirtti, Olli Kallioniemi, Antti Rannikko, Pia Siljander, Taija M. af Hällström - Theranostics 2017 cited by 229

  12. Association of tamoxifen resistance and lipid reprogramming in breast cancer

    Authors: Susanne Hultsch, Matti Kankainen, Lassi Paavolainen, Ruusu‐Maaria Kovanen, Elina Ikonen, Sara Kangaspeska, Vilja Pietiäinen, Olli Kallioniemi - BMC Cancer 2018 cited by 218

  13. Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

    Authors: Tea Pemovska, Mika Kontro, Bhagwan Yadav, Henrik Edgren, Samuli Eldfors, Agnieszka Szwajda, Henrikki Almusa, Maxim M. Bespalov, Pekka Ellonen, Erkki Elonen, Bjørn Tore Gjertsen, Riikka Karjalainen, Evgeny Kulesskiy, Sonja Lagström, Anna Lehto, Maija Lepistö, Tuija Lundán, Muntasir Mamun Majumder, Jesús M. López Martí, Pirkko Mattila, Astrid Murumägi, Satu Mustjoki, Aino Palva, Alun Parsons, Tero Pirttinen, Maria E. Rämet, Minna Suvela, Laura Turunen, Imre Västrik, Maija Wolf, Jonathan C. Knowles, Tero Aittokallio, Caroline A. Heckman, Kimmo Porkka, Olli Kallioniemi, Krister Wennerberg - Cancer Discovery 2013 cited by 406

  14. In vivo amplification of the androgen receptor gene and progression of human prostate cancer

    Authors: Tapio Visakorpi, Eija Hyytinen, Pasi A. Koivisto, Minna Tanner, Riitta Keinänen, Christian Palmberg, Aarno Palotie, Teuvo L.J. Tammela, Jorma Isola, Olli Kallioniemi - Nature Genetics 1995 cited by 1,486

  15. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

    Authors: Sirkku Pollari, Sanna-Maria Käkönen, Henrik Edgren, Maija Wolf, Pekka Kohonen, Henri Sara, Theresa A. Guise, Matthias Nees, Olli Kallioniemi - Breast Cancer Research and Treatment 2010 cited by 281

  16. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

    Authors: Heike Peterziel, Nora Jamaladdin, Dina ElHarouni, Xenia F. Gerloff, Sonja Herter, Petra Fiesel, Yannick Berker, Mirjam Blattner-Johnson, Kathrin Schramm, Barbara C. Jones, David Reuß, Laura Turunen, Aileen Friedenauer, Tim Holland‐Letz, Martin Sill, Lena Weiser, Christopher Previti, Gnanaprakash Balasubramanian, Nicolas U. Gerber, Johannes Gojo, Caroline Hutter, Ingrid Øra, Olli Lohi, Antonis Kattamis, Bram De Wilde, Frank Westermann, Stephan Tippelt, Norbert Graf, Michaela Nathrath, Monika Sparber‐Sauer, Astrid Sehested, Christof M. Kramm, Uta Dirksen, Olli Kallioniemi, Stefan M. Pfister, Cornelis M. van Tilburg, David Jones, Jani Saarela, Vilja Pietiäinen, Natalie Jäger, Matthias Schlesner, Annette Kopp‐Schneider, Sina Oppermann, Till Milde, Olaf Witt, Ina Oehme - npj Precision Oncology 2022 cited by 62

  17. Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis

    Authors: Sami Blom, Lassi Paavolainen, Dmitrii Bychkov, Riku Turkki, Petra Mäki-Teeri, Annabrita Hemmes, Katja Välimäki, Johan Lundin, Olli Kallioniemi, Teijo Pellinen - Scientific Reports 2017 cited by 160

  18. The impact of low-frequency and rare variants on lipid levels

    Authors: Ida Surakka, Momoko Horikoshi, Reedik Mägi, Antti‐Pekka Sarin, Anubha Mahajan, Vasiliki Lagou, Letizia Marullo, Teresa Ferreira, Benjamin Miraglio, Sanna Timonen, Johannes Kettunen, Matti Pirinen, Juha Karjalainen, Guðmar Þorleifsson, Sara Hägg, Jouke‐Jan Hottenga, Aaron Isaacs, Claes Ladenvall, Marian Beekman, Tõnu Esko, Janina S. Ried, Christopher P. Nelson, Christina Willenborg, Stefan Gustafsson, Harm-Jan Westra, Matthew Blades, Anton J. M. de Craen, Eco J. C. de Geus, Joris Deelen, Harald Grallert, Anders Hamsten, Aki S. Havulinna, Christian Hengstenberg, Jeanine J. Houwing‐Duistermaat, Elina Hyppönen, Lennart C. Karssen, Terho Lehtimäki, Valeriya Lyssenko, Patrik K. E. Magnusson, Evelin Mihailov, Martina Müller‐Nurasyid, John-Patrick Mpindi, Nancy L. Pedersen, Brenda W.J.H. Penninx, Markus Perola, Tune H. Pers, Annette Peters, Johan Rung, Johannes H. Smit, Valgerður Steinthórsdóttir, Martin D. Tobin, Natalia Tšernikova, Elisabeth M van Leeuwen, Jorma Viikari, Sara M. Willems, Gonneke Willemsen, Heribert Schunkert, Jeanette Erdmann, Nilesh J. Samani, Jaakko Kaprio, Lars Lind, Christian Gieger, Andres Metspalu, P. Eline Slagboom, Leif Groop, Cornelia M. van Duijn, Johan G. Eriksson, Antti Jula, Veikko Salomaa, Dorret I. Boomsma, Christopher Power, Olli T. Raitakari, Erik Ingelsson, Marjo‐Riitta Järvelin, Unnur Þorsteinsdóttir, Lude Franke, Elina Ikonen, Olli Kallioniemi, Vilja Pietiäinen, Cecilia M. Lindgren, Kari Stefansson, Aarno Palotie, Mark I. McCarthy, Andrew P. Morris, Inga Prokopenko, Samuli Ripatti - Nature Genetics 2015 cited by 409

  19. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies

    Authors: Anita Sveen, Jarle Bruun, Peter W. Eide, Ina A. Eilertsen, Lorena Ramírez, Astrid Murumägi, Mariliina Arjama, Stine A. Danielsen, Kushtrim Kryeziu, Elena Élez, Josep Tabernero, Justin Guinney, Héctor G. Pálmer, Arild Nesbakken, Olli Kallioniemi, Rodrigo Dienstmann, Ragnhild A. Lothe - Clinical Cancer Research 2017 cited by 261

  20. High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

    Authors: Kristiina Iljin, Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen, Vidal Fey, Roland C. Grafström, Merja Perälä, Olli Kallioniemi - Clinical Cancer Research 2009 cited by 245

  21. Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer

    Authors: Samir Hanash, Christina S. Baik, Olli Kallioniemi - Nature Reviews Clinical Oncology 2011 cited by 322

  22. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

    Authors: Hanna Rajala, Samuli Eldfors, Heikki Kuusanmäki, Arjan J. van Adrichem, Thomas L. Olson, Sonja Lagström, Emma Andersson, Andrés Jerez, Michael J. Clemente, Yiyi Yan, Dan Zhang, Andy Awwad, Pekka Ellonen, Olli Kallioniemi, Krister Wennerberg, Kimmo Porkka, Jaroslaw P. Maciejewski, Thomas P. Loughran, Caroline A. Heckman, Satu Mustjoki - Blood 2013 cited by 296

  23. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

    Authors: Anne Kallioniemi, Olli Kallioniemi, Damir Sudar, Denis Rutovitz, Joe W. Gray, Fred Waldman, Dan Pinkel - Science 1992 cited by 3,315

  24. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

    Authors: Olli Kallioniemi, Anne Kallioniemi, Wayne Kurisu, Ann D. Thor, L C Chen, Helene S. Smith, Fred Waldman, Daniel Pinkel, Joe W. Gray - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 cited by 560